When Can You Ban Parallel Trade?
Executive Summary
European commissioner's statements supporting countries' right to limit drug exports appears counter to EC actions against some who do.
You may also be interested in...
European Notebook: Salmonson Stays At CHMP Helm; Sandoz, AstraZeneca Build New Biologics Facilities
CHMP Chairman Tomas Salmonson re-elected for three-year term; Sandoz and AstraZeneca develop manufacturing facilities in Austria and the US respectively for biosimilars and biologics, among investments suggesting European pharmas' more confident outlook; more in this month's column
Big Pharma's EU Woes Continued In Second Quarter - Where’s The Bottom?
In addition to patent expiries, which affected pharma company performance globally, ongoing price cuts for drugs and increasing parallel trade continued to hurt pharma’s European performance in the second quarter, with the gloom unlikely to lift soon. What’s at stake is further pharma investment in Europe.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.